Curriculum · Public Health and Communicable Diseases
Antiviral therapy for herpes zoster
What it is
Herpes zoster (shingles) is an acute, unilateral, painful blistering rash caused by reactivation of latent varicella zoster virus (VZV).
How it presents
The eruption is dermatomal (zosteriform) and on one side of the body, with grouped vesicles on an erythematous base, most often on the trunk but it can be anywhere, and it is usually preceded by pain or burning.
Two sites matter more than the rest. Herpes zoster ophthalmicus is reactivation in the area supplied by the ophthalmic division of the trigeminal nerve and accounts for around 10% of cases of shingles; the rash is vesicular and around the eye, and it may or may not involve the eye itself. Hutchinson's sign, a rash on the tip or side of the nose, indicates nasociliary involvement and is a strong risk factor for ocular involvement. Ramsay Hunt syndrome (herpes zoster oticus) is an acute unilateral facial palsy caused by reactivation in the geniculate ganglion, more common in the immunosuppressed and the elderly, with moderate to severe pain around the ear and vesicles in the auditory canal or auricle.
How it is treated
Treatment is analgesics and oral antivirals, and oral aciclovir is first-line. One of the main benefits of treatment is a reduction in the incidence of post-herpetic neuralgia.
- In herpes zoster ophthalmicus, oral antiviral treatment is given for 7-10 days, ideally started within 72 hours. Topical antiviral treatment is not given in HZO. Oral corticosteroids may reduce the duration of pain but do not reduce the incidence of post-herpetic neuralgia, and ocular involvement requires urgent ophthalmology review.
- In Ramsay Hunt syndrome, treatment is oral antivirals (acyclovir) with steroids (prednisolone).
- Contact precautions are used for localized herpes zoster (shingles), whereas disseminated herpes zoster (shingles) needs airborne precautions.